Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Journal of Gastroenterology|September 26, 2022
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registryTomoyuki Satake, Chigusa Morizane, Ryoko Rikitake, et al.
Clinical Journal of Gastroenterology|December 15, 2025
Transient response to cisplatin-etoposide chemotherapy for early postoperative recurrence of large cell neuroendocrine carcinoma of the distal bile duct: a case reportTaiki Sunakawa, Masashi Kudo, Tomoyuki Satake, et al.
Cancer Research Communications|July 17, 2025
Epidemiologic Features and Age-Related Differences in Management among Patients with Gastrointestinal Stromal Tumors in Japan: A National Cancer Registry StudyHidekazu Hirano, Yoichi Naito, Toshirou Nishida, et al.
International Journal of Clinical Oncology|February 27, 2024
Current status of head and neck sarcomas in Japan in 2016-2019: an analysis using the national cancer registryRyoko Rikitake, Yu Mizushima, Seiichi Yoshimoto, et al.
Anticancer Research|August 2, 2019
Choline-deficient-diet Decreases Fibroblasts in the Circulating Tumor Cell (CTC) MicroenvironmentKana Matsuura, Atsushi Suetsugu, Tomoyuki Satake, et al.
Anticancer Research|June 4, 2021
Exosome Transfer Between Pancreatic-cancer Cells Is Associated With Metastasis in a Nude-mouse ModelHironao Ichikawa, Atsushi Suetsugu, Tomoyuki Satake, et al.
Frontiers in Oncology|August 7, 2023
Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinomaTomoyuki Satake, Taro Shibuki, Kazuo Watanabe, et al.
Anticancer Research|August 2, 2019
Color-coded Imaging of the Fate of Cancer-cell-derived Exosomes During Pancreatic Cancer Metastases in a Nude-mouse ModelTomoyuki Satake, Atsushi Suetsugu, Miki Nakamura, et al.
Anticancer Research|October 3, 2018
Color-coded Imaging of the Circulating Tumor Cell MicroenvironmentTomoyuki Satake, Atsushi Suetsugu, Miki Nakamura, et al.
International Journal of Clinical Oncology|May 31, 2022
The influence of UGT1A1 polymorphisms on modified FOLFIRINOX dose in double-variant-type patients with advanced pancreatic cancerTomoyuki Satake, Chigusa Morizane, Yuta Maruki, et al.
Pageof 6